Login
Home / APNHF : OTC
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis News Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Aspen Pharmacare Holdings Limited

$8.9 +$2.67 (+42.79%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$8.9
Day Range
$8.8$8.9
Year Range
$6.23$8.9
Market Cap
3.95B
AVG Volume
6
Trailing/Forward PE
26.31/0.83
PEG ratio
4.13
Dividend Yield
1.35%
Next Earnings Date
2027-03-11
Primary Exchange
Other OTCUS
Revenue (ZAR)
010B20B30B22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
Net Income (ZAR)
-4B-2B02B4B22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
Operating Income (ZAR)
02B4B6B22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
EBITDA (ZAR)
-2.5B02.5B5B7.5B22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
Cash Flows (ZAR)
-1B01B2B3B22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
EPS (ZAR)
-10-5051022 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
Expenses (ZAR)
02B4B6B8BR&DSG&ACapex22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
Cash & Debt (ZAR)
010B20B30B40BCashLong Term DebtShort Term Debt22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
Debt ratios
-1012322 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
Margins
0%20%40%60%22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
Return on Capital
-5%-2.5%0%2.5%5%22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
Shares Outstanding
0200M400M600M22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
Dividends (ZAR)
00.10.20.3Oct 16Oct 17Oct 18Sep 21Sep 22Sep 23Sep 24Oct 25Oct 26
Book Value Per Share (ZAR)
05010015020022 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
Total Assets (ZAR)
050B100B150B22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
PE Ratio
01020304050med 16.37Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Free Cash Flow Yield
2.5%5%7.5%10%12.5%med 7.22%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price to Sales
0.40.60.811.21.4med 0.75Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
EV/EBITDA
345678med 5.65Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price/Operating Cashflow
46810med 5.12Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price to Book
0.40.60.811.21.4med 0.78Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Aspen Pharmacare Holdings Limited
APNHF
Stockpicker

Video analysis: APNHF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: APNHF

Aspen sees Mounjaro Africa sales above $124 million in 2027

reuters.com · 3 Sep 2026

Aspen sees Mounjaro Africa sales above $124 million in 2027

Aspen Pharmacare expects African sales ‌of Eli Lilly's blockbuster weight-loss and diabetes drug Mounjaro to exceed 2 billion rand ($124 million) in its current financial year, buoyed by surging demand in South Africa and planned launches in ​Nigeria and Kenya.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.